ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1,4,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3,1,Alopecia scarring,Alopecias,Skin appendage conditions,Skin,N
4,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
4,4,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
4,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
5,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
6,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
7,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
8,2,Lacunar stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
8,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
9,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
9,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
9,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
10,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
10,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
10,4,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
10,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
12,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
12,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
12,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
13,1,Sensation of foreign body,Feelings and sensations NEC,General system disorders NEC,Genrl,N
14,1,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
15,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
15,2,Dysplastic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
16,1,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
16,2,Lipoma,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
16,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
17,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
18,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
18,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
18,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
19,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
20,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
20,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
21,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
21,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
21,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
21,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
21,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
21,6,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
22,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
23,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
23,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
23,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
23,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
24,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
24,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
25,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
25,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
26,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
26,2,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
27,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
27,2,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
28,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
28,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
29,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
29,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
30,1,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
31,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
31,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
31,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
31,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
32,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
32,2,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
33,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
33,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
33,3,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
34,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
35,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
35,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
36,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
36,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
36,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
37,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
37,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
37,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
37,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
38,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
39,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
39,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
39,3,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
39,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
39,5,Eye oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
39,6,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
39,7,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
39,8,Headache,Headaches NEC,Headaches,Nerv,N
39,9,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
39,10,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
39,11,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
39,12,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
39,13,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
39,14,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
39,15,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
39,16,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
39,17,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
39,18,Myalgia,Muscle pains,Muscle disorders,Musc,N
39,19,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
39,20,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
39,21,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
39,22,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
39,23,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
39,24,Semen viscosity decreased,Fertility analyses and other reproductive function procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
39,25,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
39,26,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
39,27,Xanthopsia,Visual colour distortions,Vision disorders,Eye,N
40,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
40,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
40,3,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
40,4,Headache,Headaches NEC,Headaches,Nerv,N
40,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
40,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
40,7,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
40,8,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
40,9,Xanthopsia,Visual colour distortions,Vision disorders,Eye,N
41,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
41,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
42,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
43,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
44,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
45,1,Headache,Headaches NEC,Headaches,Nerv,N
46,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
46,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
46,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
47,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
48,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
49,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
50,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
51,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
51,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
52,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
53,1,Thyroiditis subacute,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
54,1,Headache,Headaches NEC,Headaches,Nerv,N
54,2,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
54,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
54,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
54,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
55,1,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
55,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
56,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
56,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
57,1,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
57,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
57,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
57,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
57,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
58,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
58,2,Headache,Headaches NEC,Headaches,Nerv,N
58,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
59,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
59,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
59,3,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
59,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
59,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
60,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
60,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
61,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
61,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
61,3,Triple negative breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
62,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
63,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
63,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
63,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
63,4,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
63,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
63,6,Sjogren's syndrome,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
64,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
64,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
64,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
64,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
65,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
66,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
67,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
68,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
69,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
70,1,Acarodermatitis,Ectoparasitic infestations,Ectoparasitic disorders,Infec,N
70,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
70,3,Muscular dystrophy,Non-site specific muscle disorders congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
71,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
71,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
71,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
72,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
72,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
72,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
73,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
74,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
75,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
75,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
75,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
76,1,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
77,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
78,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
78,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
78,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
79,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
80,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
80,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
80,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
80,4,Injection site oedema,Injection site reactions,Administration site reactions,Genrl,N
80,5,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
80,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
81,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
81,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
81,3,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
82,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
82,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
82,3,Sensation of foreign body,Feelings and sensations NEC,General system disorders NEC,Genrl,N
83,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
83,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
84,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
85,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
85,2,Foreign body in throat,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
85,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
86,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
87,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
87,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
87,3,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
87,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
88,1,Breast cancer stage II,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
89,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
90,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
90,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
90,3,Williams syndrome,Cardiac valve disorders congenital,Cardiac and vascular disorders congenital,Cong,N
91,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
92,1,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
93,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
94,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
94,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
95,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
95,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
95,3,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
95,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
95,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
96,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
96,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
96,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
97,1,Oropharyngeal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
98,1,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
99,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
100,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
101,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
101,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
102,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
103,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
104,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
104,2,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
105,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
106,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
107,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
108,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
108,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
108,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
109,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
109,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
109,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
109,4,Double stranded DNA antibody,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
109,5,Headache,Headaches NEC,Headaches,Nerv,N
109,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
109,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
109,8,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
109,9,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
109,10,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
109,11,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
109,12,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
109,13,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
109,14,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
109,15,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
110,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
111,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
111,2,Enteritis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
112,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
113,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
113,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
113,3,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
114,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
114,2,Lymphocele,Lymphangiopathies,Lymphatic vessel disorders,Vasc,N
115,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
116,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
117,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
118,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
119,1,Spirochaetal infection,Treponema infections,Bacterial infectious disorders,Infec,N
120,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
121,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
122,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
122,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
122,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
122,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
123,1,Diverticulitis intestinal perforated,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
124,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
125,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
126,1,Faecal calprotectin,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
126,2,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
126,3,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
127,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
128,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
129,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
130,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
130,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
131,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
132,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
133,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
134,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
135,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
136,1,Body tinea,Tinea infections,Fungal infectious disorders,Infec,N
137,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
137,2,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
138,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
139,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
139,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
140,1,Fournier's gangrene,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
141,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
141,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
141,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
141,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
141,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
141,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
141,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
142,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
142,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
142,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
142,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
142,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
142,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
143,1,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
144,1,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
145,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
145,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
146,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
147,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
148,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
149,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
150,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
151,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
151,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
152,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
153,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
153,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
153,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
153,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
153,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
154,1,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
154,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
154,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
155,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
156,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
157,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
158,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
159,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
160,1,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
161,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
162,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
162,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
162,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
162,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
163,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
164,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
165,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
165,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
165,3,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
166,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
167,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
168,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
169,1,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
169,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
169,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
169,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
170,1,Change of bowel habit,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
170,2,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
171,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
172,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
173,1,Headache,Headaches NEC,Headaches,Nerv,N
174,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
174,2,Migraine,Migraine headaches,Headaches,Nerv,N
175,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
175,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
176,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
176,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
176,3,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
176,4,Injection related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
176,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
176,6,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
177,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
178,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
178,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
179,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
179,2,Twin pregnancy,Multiple pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
180,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
181,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
182,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
183,1,Hordeolum,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
184,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
184,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
185,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
186,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
187,1,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
187,2,Shoulder fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
188,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
189,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
189,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
190,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
191,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
191,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
191,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
191,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
191,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
192,1,Ecchymosis,Purpura and related conditions,Skin vascular abnormalities,Skin,N
193,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
194,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
194,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
195,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
195,2,Headache,Headaches NEC,Headaches,Nerv,N
195,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
195,4,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
196,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
196,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
196,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
197,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
198,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
199,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
200,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
201,1,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
201,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
201,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
202,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
203,1,Trigger finger,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
204,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
205,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
206,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
206,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
207,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
208,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
209,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
209,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
210,1,Brain contusion,Cerebral injuries NEC,Injuries NEC,Inj&P,N
210,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
211,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
212,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
213,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
214,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
215,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
216,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
217,1,Lichen planus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
218,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
218,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
218,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
218,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
218,5,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
218,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
218,7,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
218,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
